Lining Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lining Xu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Anyi Guo
3 shared publications- Renxian Wang
JST Sarcopenia Research Centre, National Center for Orthopaedics, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Capital Medical University, Beijing, 100035, China
3 shared publications - Yajun Liu
School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China
3 shared publications Dingding Wang
JST Sarcopenia Research Centre National Center for Orthopaedics Beijing Research Institute of Traumatology and Orthopaedics Beijing Jishuitan Hospital Capital Medical University Beijing 100035 China
2 shared publicationsJianxun Guo
2 shared publicationsLing Wang
JST Sarcopenia Research Centre National Center for Orthopaedics Beijing Research Institute of Traumatology and Orthopaedics Beijing Jishuitan Hospital Capital Medical University Beijing 100035 China
2 shared publications
Latest Publications
- 12 June 2026
- Published by Springer Nature in Phenomics
- Vol. 6 (5) , 575-591
Swimming Training Alters Immune Cell Spatiotemporal Distribution to Mitigate Fat Infiltration and Enhance Muscle Regeneration
- 12 June 2026
- Published by Springer Nature in Phenomics
- Vol. 6 (5) , 575-591
Swimming Training Alters Immune Cell Spatiotemporal Distribution to Mitigate Fat Infiltration and Enhance Muscle Regeneration
- Open Access
Nanoparticle‐Driven Skeletal Muscle Repair and Regeneration Through Macrophage‐Muscle Stem Cell Interaction
Macrophages are key innate immune cells in the muscle environment of sarcopenia patients, significantly influencing muscle stem cell (MuSC) proliferation and differentiation. However, prolonged activation of macrophages can hinder muscle recovery. In this study, it synthesizes lipoic acid‐modified gold nanoparticles (LA‐Au NPs) of varying sizes to evaluate their biocompatibility and immunomodulatory effects. The findings demonstrate that LA‐Au NPs exhibit excellent biocompatibility with macrophages and promoted M2 polarization in a size‐dependent manner. Mechanistically, LA‐Au NPs facilitated metabolic reprogramming in macrophages by enhancing lysosomal autophagy and mitochondrial oxidative phosphorylation. Furthermore, macrophages are shown to chemotax toward MuSCs, regulating their proliferation via the chemokine system, inhibiting MuSC apoptosis, and enhancing differentiation under inflammatory conditions. In vivo studies have confirmed the safety and efficacy of LA‐Au NPs in sarcopenia mice. To further enhance the effectiveness of LA‐Au NPs, it investigates a delivery strategy that involves preconditioning macrophages with LA‐Au NPs (Mac@Au NPs). Compared to the direct injection of LA‐Au NPs, Mac@Au NPs demonstrate significantly greater benefits for muscle repair. This highlights the potential of macrophage therapy as a promising strategy for effective muscle regeneration and therapeutic intervention in sarcopenia.
Open AccessNanoparticle‐Driven Skeletal Muscle Repair and Regeneration Through Macrophage‐Muscle Stem Cell Interaction
Macrophages are key innate immune cells in the muscle environment of sarcopenia patients, significantly influencing muscle stem cell (MuSC) proliferation and differentiation. However, prolonged activation of macrophages can hinder muscle recovery. In this study, it synthesizes lipoic acid‐modified gold nanoparticles (LA‐Au NPs) of varying sizes to evaluate their biocompatibility and immunomodulatory effects. The findings demonstrate that LA‐Au NPs exhibit excellent biocompatibility with macrophages and promoted M2 polarization in a size‐dependent manner. Mechanistically, LA‐Au NPs facilitated metabolic reprogramming in macrophages by enhancing lysosomal autophagy and mitochondrial oxidative phosphorylation. Furthermore, macrophages are shown to chemotax toward MuSCs, regulating their proliferation via the chemokine system, inhibiting MuSC apoptosis, and enhancing differentiation under inflammatory conditions. In vivo studies have confirmed the safety and efficacy of LA‐Au NPs in sarcopenia mice. To further enhance the effectiveness of LA‐Au NPs, it investigates a delivery strategy that involves preconditioning macrophages with LA‐Au NPs (Mac@Au NPs). Compared to the direct injection of LA‐Au NPs, Mac@Au NPs demonstrate significantly greater benefits for muscle repair. This highlights the potential of macrophage therapy as a promising strategy for effective muscle regeneration and therapeutic intervention in sarcopenia.
- Open Access
- 11 March 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101653
Gold nanoparticles modulate macrophage polarization to promote skeletal muscle regeneration
- 11 March 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101653
Open AccessGold nanoparticles modulate macrophage polarization to promote skeletal muscle regeneration